help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clevenger, C. V.
Right arrow Articles by Prystowsky, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clevenger, C. V.
Right arrow Articles by Prystowsky, M. B.

Endocrinology, Vol 127, 3151-3159, Copyright © 1990 by Endocrine Society


ARTICLES

Interleukin-2 driven nuclear translocation of prolactin in cloned T- lymphocytes

CV Clevenger, AL Sillman and MB Prystowsky
Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia 19104.

The nuclear translocation of PRL is demonstrated at the immunofluorescence and electron microscopic (EM) levels in interleukin- 2 (IL2)-stimulated cloned T-cells and concanavalin A-stimulated splenocytes. This translocation occurs 2-10 h after IL2 stimulation, and is reversed by the addition of anti-PRL antiserum into the extracellular culture medium. The nuclear localization of PRL in IL2 stimulated T-cells was confirmed by postembedding immunogold EM. The nuclear uptake of PRL after IL2 stimulation was further documented by EM studies using PRL-colloidal gold conjugates. These studies suggest that the intranuclear PRL is translocated from the extracellular medium via an endosomal/lysosomal pathway over a period of several hours. Finally, the requirement for PRL no later than 6 h after IL2 stimulation is demonstrated through the reversible inhibition of T-cell growth with anti-PRL antiserum.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
C. V. Clevenger
Roles and Regulation of Stat Family Transcription Factors in Human Breast Cancer
Am. J. Pathol., November 1, 2004; 165(5): 1449 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M. Ito, M. Nakasato, T. Suzuki, S. Sakai, M. Nagata, and F. Aoki
Localization of Janus Kinase 2 to the Nuclei of Mature Oocytes and Early Cleavage Stage Mouse Embryos
Biol Reprod, July 1, 2004; 71(1): 89 - 96.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. V. Clevenger, P. A. Furth, S. E. Hankinson, and L. A. Schuler
The Role of Prolactin in Mammary Carcinoma
Endocr. Rev., February 1, 2003; 24(1): 1 - 27.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. A. Rycyzyn and C. V. Clevenger
The intranuclear prolactin/cyclophilin B complex as a transcriptional inducer
PNAS, May 14, 2002; 99(10): 6790 - 6795.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. A. Rycyzyn, S. C. Reilly, K. O’Malley, and C. V. Clevenger
Role of Cyclophilin B in Prolactin Signal Transduction and Nuclear Retrotranslocation
Mol. Endocrinol., August 1, 2000; 14(8): 1175 - 1186.
[Abstract] [Full Text]


Home page
HypertensionHome page
R. Re
The Nature of Intracrine Peptide Hormone Action
Hypertension, October 1, 1999; 34(4): 534 - 538.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
I. Leav, F. B. Merk, K. F. Lee, M. Loda, M. Mandoki, J. E. McNeal, and S.-m. Ho
Prolactin Receptor Expression in the Developing Human Prostate and in Hyperplastic, Dysplastic, and Neoplastic Lesions
Am. J. Pathol., March 1, 1999; 154(3): 863 - 870.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M Perrot-Applanat, O Gualillo, H Buteau, M Edery, and P. Kelly
Internalization of prolactin receptor and prolactin in transfected cells does not involve nuclear translocation
J. Cell Sci., January 5, 1997; 110(9): 1123 - 1132.
[Abstract] [PDF]


Home page
ScienceHome page
C. Clevenger, S. Altmann, and M. Prystowsky
Requirement of nuclear prolactin for interleukin-2--stimulated proliferation of T lymphocytes
Science, July 5, 1991; 253(5015): 77 - 79.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society